Clinical Trial Update: CKD-828 S-Amlodipine Non-Responder Trial [Phase 3]

View source ↗

Summary

Phase 3 trial update on CKD-828 S-Amlodipine for hypertension; the non-responder study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CKD-828 S-Amlodipine (S-Amlodipine)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 3 | Status: COMPLETED